Skip to main content
. 2022 Jul 11;3(4):100130. doi: 10.1016/j.xhgg.2022.100130

Table 2.

Summary of the HTT haplogroups/haplotypes and associated allele structures in disease and non-disease alleles

Haplogroups Haplotypes Allele structures Non-disease
Disease
n % n %
A ∗A2a Q1-2-2-7-2 1 1.5
∗A2b Q1-2-2-7-2 13 3.4 1 1.5
A4a Q1-2-2-7-2
Q1-2-2-12-2
Q1-2-2-13-2
5
1
1
1.3
0.3
0.3
3

4.5

A4b Q1-2-2-7-2 2 0.5 5 7.5
A6 Q1-2-2-7-2 34 8.9
B B1 Q1-2-2-9-2 1 0.3 1 1.5
B2 Q1-2-0-9-2
Q1-0-0-9-2
Q1-4-2-4-3
25

6.6

29
2
1
43.3
3.0
1.5
C C2 Q1-4-2-7-3
Q1-2-2-8-2
21
5
5.5
1.3


C4 Q1-2-2-9-2 21 5.5 1 1.5
C4c Q1-2-2-6-2 11 2.9
C5 Q1-2-2-10-2
Q1-2-2-11-2
Q1-2-2-10-3
Q1-2-0-9-2
Q1-4-2-10-2
69
18
1
2
4
18.1
4.7
0.3
0.5
1.0
19



28.4



C8 Q1-2-2-9-2 7 1.8
C-SA C3 Q1-2-2-10-2
Q1-2-2-9-3
1
90
0.3
23.6


C9 Q1-2-2-6-3
Q1-2-2-7-2
2
7
0.5
1.8
4
6.0
C10 Q1-2-2-4-3 1 0.3
Other O Q1-2-2-7-2
Q1-2-2-9-3
Q1-2-2-10-2
36
2
1
9.4
0.5
0.3




Total #381 100.0 67 100.0

The two haplotypes that had not been previously identified in African ancestry individuals are indicated by an asterisk (∗). The most common non-disease and disease haplogroup/haplotype are indicated in underlined italics. The most common disease allele structure Q1-2-0-9-2 (29 out of 67 = 43.3%) is indicated in italics. Two samples (one disease allele and three non-disease alleles) from the sequence diversity analysis presented in Table 1 were excluded due to unsuccessful tag-SNP genotyping (#).